Literature DB >> 7819001

Serum intact parathyroid hormone and ionised calcium concentration in children with renal insufficiency.

S E Ledermann1, A Johnson, M J Dillon, R S Trompeter, T M Barratt.   

Abstract

We report our experience of the use of an immunoradiometric assay for intact parathyroid hormone (i-PTH) and the measurement of plasma ionised calcium concentration (PCa2+) in 73 children with chronic renal insufficiency (CRI); plasma creatinine concentration (PCr) 52-856 mumol/l. There was a poor correlation between i-PTH and PCr (r = 0.10, n = 552) compared with that for C-terminal PTH and PCr (r = 0.60, n = 248), suggesting that the i-PTH assay is independent of renal function in this group of treated children. A clear response of i-PTH to a low total plasma Ca (tPCa) and PCa2+ was observed. There was a significant positive correlation between both tPCa and PCa2+ (r = 0.50, n = 389) and the fraction of Ca2+ (the fraction of tCa which was ionised) and PCa2+ (r = 0.50, n = 389). The finding of a low or normal PCa2+ with a low calculated fraction of Ca2+ was frequently observed, i.e. the measured tPCa was unexpectedly high, suggesting complexing of Ca2+ by accumulated anions in CRI. There was a poor relationship between the plasma albumin concentration and both bound plus complexed Ca (tPCa minus PCa2+) and the fraction of Ca2+ (r = 0.15 and -0.17, respectively). The positive predictive value for a raised i-PTH of a tubular reabsorption of phosphate of less than 80% was 0.87, and of an alkaline phosphatase greater than 800 U/l was 0.37.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7819001     DOI: 10.1007/bf00858126

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  25 in total

Review 1.  The clinical value of ionised calcium assays.

Authors:  T A Gray; C R Paterson
Journal:  Ann Clin Biochem       Date:  1988-05       Impact factor: 2.057

2.  Is intact PTH a sensitive biochemical indicator of deranged calcium homeostasis in vitamin D deficiency?

Authors:  J P Ashby; D J Newman; M G Rinsler
Journal:  Ann Clin Biochem       Date:  1989-07       Impact factor: 2.057

3.  Role of 1,25-dihydroxyvitamin D on the skeletal resistance to parathyroid hormone.

Authors:  T Galceran; K J Martin; J J Morrissey; E Slatopolsky
Journal:  Kidney Int       Date:  1987-12       Impact factor: 10.612

4.  Impaired parathyroid hormone metabolism in patients with chronic renal failure.

Authors:  J Freitag; K J Martin; K A Hruska; C Anderson; M Conrades; J Ladenson; S Klahr; E Slatopolsky
Journal:  N Engl J Med       Date:  1978-01-05       Impact factor: 91.245

5.  Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium.

Authors:  J A Delmez; C Tindira; P Grooms; A Dusso; D W Windus; E Slatopolsky
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

6.  Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia.

Authors:  S R Nussbaum; R J Zahradnik; J R Lavigne; G L Brennan; K Nozawa-Ung; L Y Kim; H T Keutmann; C A Wang; J T Potts; G V Segre
Journal:  Clin Chem       Date:  1987-08       Impact factor: 8.327

7.  Failure of total calcium corrected for protein, albumin, and pH to correctly assess free calcium status.

Authors:  J H Ladenson; J W Lewis; J C Boyd
Journal:  J Clin Endocrinol Metab       Date:  1978-06       Impact factor: 5.958

8.  The spectrum of bone disease in end-stage renal failure--an evolving disorder.

Authors:  D J Sherrard; G Hercz; Y Pei; N A Maloney; C Greenwood; A Manuel; C Saiphoo; S S Fenton; G V Segre
Journal:  Kidney Int       Date:  1993-02       Impact factor: 10.612

9.  Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD.

Authors:  I B Salusky; J W Coburn; J Brill; J Foley; E Slatopolsky; R N Fine; W G Goodman
Journal:  Kidney Int       Date:  1988-05       Impact factor: 10.612

10.  Comparative studies of total and ionized serum calcium values in normal subjects and patients with renal disorders.

Authors:  M F Burritt; A M Pierides; K P Offord
Journal:  Mayo Clin Proc       Date:  1980-10       Impact factor: 7.616

View more
  1 in total

1.  The treatment of renal osteodystrophy.

Authors:  S P Rigden
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.